(Q38890459)

7 September 2017

title

Program Death 1 Immune Checkpoint and Tumor Microenvironment: Implications for Patients With Intrahepatic Cholangiocarcinoma (English)

1 reference

7 September 2017

0 references

8

Timothy M Pawlik

1 reference

7 September 2017

Faiz Gani

1

1 reference

7 September 2017

Neeraja Nagarajan

2

1 reference

7 September 2017

Yuhree Kim

3

1 reference

7 September 2017

Qingfeng Zhu

4

1 reference

7 September 2017

Lan Luan

5

1 reference

7 September 2017

Feriyl Bhaijjee

6

1 reference

7 September 2017

Robert A Anders

7

1 reference

7 September 2017

publication date

24 March 2016

1 reference

Annals of Surgical Oncology

7 September 2017

published in

1 reference

7 September 2017

volume

23

1 reference

7 September 2017

issue

8

1 reference

7 September 2017

page(s)

2610-2617

1 reference

Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5101-Y

Evidence-based approach to cholangiocarcinoma: a systematic review of the current literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5101-Y

The epidemiology of cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5101-Y

Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5101-Y

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5101-Y

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5101-Y

Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5101-Y

PD-L1 expression in small cell neuroendocrine carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5101-Y

The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5101-Y

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5101-Y

PD-1/PD-L1 blockade together with vaccine therapy facilitates effector T-cell infiltration into pancreatic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5101-Y

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5101-Y

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5101-Y

Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5101-Y

PD-L1 and HLA Class I Antigen Expression and Clinical Course of the Disease in Intrahepatic Cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5101-Y

Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5101-Y

Risk factors for cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5101-Y

Infrequent microsatellite instability in liver fluke infection‐associated intrahepatic cholangiocarcinomas from Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5101-Y

10.1245/S10434-016-5101-Y

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

1004744850

0 references

1 reference